127 related articles for article (PubMed ID: 7810701)
1. Transforming growth factor-beta expression in macrophages during hypercholesterolemic states.
Ding G; van Goor H; Frye J; Diamond JR
Am J Physiol; 1994 Dec; 267(6 Pt 2):F937-43. PubMed ID: 7810701
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis.
Ding G; Pesek-Diamond I; Diamond JR
Am J Physiol; 1993 Apr; 264(4 Pt 2):F577-84. PubMed ID: 8476071
[TBL] [Abstract][Full Text] [Related]
3. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
Diamond JR; Pesek I
Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
[TBL] [Abstract][Full Text] [Related]
4. Early glomerular changes in rats with dietary-induced hypercholesterolemia.
Guijarro C; Kasiske BL; Kim Y; O'Donnell MP; Lee HS; Keane WF
Am J Kidney Dis; 1995 Jul; 26(1):152-61. PubMed ID: 7611247
[TBL] [Abstract][Full Text] [Related]
5. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome.
Diamond JR; Ding G; Frye J; Diamond IP
Am J Pathol; 1992 Oct; 141(4):887-94. PubMed ID: 1415482
[TBL] [Abstract][Full Text] [Related]
6. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis.
Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y
Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620
[TBL] [Abstract][Full Text] [Related]
7. Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis.
Pesek-Diamond I; Ding G; Frye J; Diamond JR
Am J Physiol; 1992 Nov; 263(5 Pt 2):F776-83. PubMed ID: 1443168
[TBL] [Abstract][Full Text] [Related]
8. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619
[TBL] [Abstract][Full Text] [Related]
9. Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor-beta in experimental glomerular sclerosis.
Fukui M; Nakamura T; Ebihara I; Nagaoka I; Tomino Y; Koide H
J Lab Clin Med; 1993 Feb; 121(2):224-34. PubMed ID: 8094426
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.
Park YS; Guijarro C; Kim Y; Massy ZA; Kasiske BL; Keane WF; O'Donnell MP
Am J Kidney Dis; 1998 Jan; 31(1):190-4. PubMed ID: 9428473
[TBL] [Abstract][Full Text] [Related]
11. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H
Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567
[TBL] [Abstract][Full Text] [Related]
12. Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages.
Diamond JR; Pesek-Diamond I
Am J Physiol; 1991 Jun; 260(6 Pt 2):F779-86. PubMed ID: 2058701
[TBL] [Abstract][Full Text] [Related]
13. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.
Diamond JR; Pesek I; Ruggieri S; Karnovsky MJ
Am J Physiol; 1989 Nov; 257(5 Pt 2):F798-807. PubMed ID: 2589483
[TBL] [Abstract][Full Text] [Related]
14. Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis.
Nakamura T; Ebihara I; Fukui M; Osada S; Nagaoka I; Horikoshi S; Tomino Y; Koide H
Clin Immunol Immunopathol; 1993 Jan; 66(1):33-42. PubMed ID: 8095004
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
16. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Grond J; Weening JJ; Elema JD
Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis.
Jones CL; Buch S; Post M; McCulloch L; Liu E; Eddy AA
Kidney Int; 1991 Dec; 40(6):1020-31. PubMed ID: 1762303
[TBL] [Abstract][Full Text] [Related]
18. Altered glomerular steady-state levels of tumour necrosis factor-alpha mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats.
Nakamura T; Ebihara I; Fukui M; Takahashi T; Tomino Y; Koide H
Clin Sci (Lond); 1993 Mar; 84(3):349-56. PubMed ID: 8384958
[TBL] [Abstract][Full Text] [Related]
19. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats.
Ma LJ; Jha S; Ling H; Pozzi A; Ledbetter S; Fogo AB
Kidney Int; 2004 Jan; 65(1):106-15. PubMed ID: 14675041
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
Fernandez L; Romero M; Rincón J; Mosquera J
Nephron Exp Nephrol; 2003; 94(2):e55-65. PubMed ID: 12845231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
